Trial intelligence / Profile preview

Adsorbed Acellular DTP Combined Vaccine in Healthy Infants

CTR20150654Phase 3Completed

Sponsor
Zhejiang Weixin Biopharmaceutical
Start
Nov 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of adsorbed acellular diphtheria-tetanus-pertussis combined vaccine in pertussis, diphtheria, Tetanus, sponsored by Zhejiang Weixin Biopharmaceutical. Started Nov 2015; status: completed.

02

Drugs

adsorbed acellular diphtheria-tetanus-pertussis combined vaccine
03

Conditions

pertussisdiphtheriaTetanus

Beyond the preview

Go deeper on CTR20150654.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150654.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call